Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Forget the TV clichés about Oxford – all punting and pass the port. The 925-year-old university is full of the most amazing people who are helping and benefiting the world, well beyond the quads and spires, says Professor Chas Bountra, the university’s Pro-Vice-Chancellor for Innovation. After the events of the last two years - and the COVID-19 vaccine [2.5 billion doses delivered and counting] - this most enthusiastic champion of Oxford maintains there can be no doubt, innovation is part and parcel of the historic university’s future. Who knows what is coming next, he says, expectantly.

Professor Chas Bountra at the Old Road Campus, Oxford University © John Cairns

‘Everyone across the university has been inspired by the vaccine team,’ insists Professor Bountra. ‘They have seen what is feasible...[the creation of the vaccine and the work with Astra Zeneca] must be one of the biggest knowledge transfers in history.’

Professor Bountra is fizzing with undisguised enthusiasm, as he discusses everything from a dementia cure [do not count on it], to the COVID-19 vaccine [just fantastic] to the faculty [incredible] and the students [astonishing]. He really does not want to talk about himself – although this is supposed to be an interview about him. The self-effacing professor wants to talk only about Oxford and the future – ‘far more interesting’.

He maintains, ‘I’m so proud of what the vaccine team achieved...people wanted hope, they were desperate for hope and our colleagues gave them hope, and eventually a route out of this wretched pandemic. People looked to scientists to come up with answers, people were scared and some still are scared....and worried.’

This, he suggests is the beginning of a new age, he says, ‘Everyone at Oxford wants to come up with solutions for the world’s biggest problems. They’re inspired.’

Read the full story on the University of Oxford website

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.